Your browser doesn't support javascript.
loading
Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.
Modi, N D; Danell, N O; Perry, R N A; Abuhelwa, A Y; Rathod, A; Badaoui, S; McKinnon, R A; Haseloff, M; Shahnam, A; Swain, S M; Welslau, M; Sorich, M J; Hopkins, A M.
Afiliación
  • Modi ND; College of Medicine and Public Health, Flinders University, South Australia.
  • Danell NO; College of Medicine and Public Health, Flinders University, South Australia.
  • Perry RNA; College of Medicine and Public Health, Flinders University, South Australia.
  • Abuhelwa AY; College of Medicine and Public Health, Flinders University, South Australia.
  • Rathod A; College of Medicine and Public Health, Flinders University, South Australia.
  • Badaoui S; College of Medicine and Public Health, Flinders University, South Australia.
  • McKinnon RA; College of Medicine and Public Health, Flinders University, South Australia.
  • Haseloff M; College of Medicine and Public Health, Flinders University, South Australia.
  • Shahnam A; Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia.
  • Swain SM; University of Georgetown Medical Center, Washington DC, USA.
  • Welslau M; Onkologie Aschaffenburg, Aschaffenburg, Germany.
  • Sorich MJ; College of Medicine and Public Health, Flinders University, South Australia.
  • Hopkins AM; College of Medicine and Public Health, Flinders University, South Australia. Electronic address: ashley.hopkins@flinders.edu.au.
ESMO Open ; 7(3): 100475, 2022 06.
Article en En | MEDLINE | ID: mdl-35490579

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido